Shunda Du

2.6k total citations
126 papers, 1.5k citations indexed

About

Shunda Du is a scholar working on Oncology, Surgery and Hepatology. According to data from OpenAlex, Shunda Du has authored 126 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Oncology, 43 papers in Surgery and 36 papers in Hepatology. Recurrent topics in Shunda Du's work include Cholangiocarcinoma and Gallbladder Cancer Studies (29 papers), Hepatocellular Carcinoma Treatment and Prognosis (26 papers) and Liver Disease Diagnosis and Treatment (16 papers). Shunda Du is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (29 papers), Hepatocellular Carcinoma Treatment and Prognosis (26 papers) and Liver Disease Diagnosis and Treatment (16 papers). Shunda Du collaborates with scholars based in China, United States and Germany. Shunda Du's co-authors include Yilei Mao, Huayu Yang, Xinting Sang, Haitao Zhao, Bao Jin, Shouxian Zhong, Yiyao Xu, Gang Xu, Xin Lu and Haifeng Xu and has published in prestigious journals such as The Lancet, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Shunda Du

107 papers receiving 1.5k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Shunda Du 463 394 366 363 346 126 1.5k
Xiangcheng Li 532 1.1× 505 1.3× 279 0.8× 601 1.7× 648 1.9× 111 2.1k
Francesco Vasuri 260 0.6× 512 1.3× 433 1.2× 469 1.3× 424 1.2× 125 1.5k
Eun Sun Jung 660 1.4× 532 1.4× 542 1.5× 436 1.2× 596 1.7× 113 2.1k
Xin Yin 525 1.1× 540 1.4× 305 0.8× 723 2.0× 592 1.7× 100 2.1k
Xiaolu Ma 529 1.1× 207 0.5× 155 0.4× 252 0.7× 152 0.4× 43 1.1k
Hee Chul Yu 535 1.2× 646 1.6× 425 1.2× 232 0.6× 905 2.6× 123 1.9k
Patrick Starlinger 529 1.1× 701 1.8× 566 1.5× 334 0.9× 511 1.5× 129 1.7k
Klaus J. Schmitz 401 0.9× 184 0.5× 147 0.4× 514 1.4× 425 1.2× 51 1.4k
Feng Han 240 0.5× 218 0.6× 189 0.5× 234 0.6× 151 0.4× 59 969
Xiaoping Chen 564 1.2× 1.2k 3.1× 554 1.5× 512 1.4× 741 2.1× 111 2.2k

Countries citing papers authored by Shunda Du

Since Specialization
Citations

This map shows the geographic impact of Shunda Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shunda Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shunda Du more than expected).

Fields of papers citing papers by Shunda Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shunda Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shunda Du. The network helps show where Shunda Du may publish in the future.

Co-authorship network of co-authors of Shunda Du

This figure shows the co-authorship network connecting the top 25 collaborators of Shunda Du. A scholar is included among the top collaborators of Shunda Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shunda Du. Shunda Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Xiaokun, Y.F. Zhang, Xueshuai Wan, et al.. (2025). Adjuvant TACE Improves Prognosis After Resection in Dual-Phenotype Hepatocellular Carcinoma: A Propensity Score-Matched Study. Journal of Hepatocellular Carcinoma. Volume 12. 2213–2224.
2.
3.
4.
Du, Shunda, Yuanhui Li, Shuai Liu, et al.. (2025). Association between post-COVID-19 sleep disturbance and neurocognitive function: a comparative study based on propensity score matching. Journal of Zhejiang University SCIENCE B. 26(2). 172–184. 1 indexed citations
5.
6.
Sun, Hang, Yan Wang, Minghao Sun, et al.. (2024). Developing Patient-Derived 3D-Bioprinting models of pancreatic cancer. Journal of Advanced Research. 74. 165–174. 5 indexed citations
7.
Zhang, Jiangang, Yiran Li, Huiyu Yang, et al.. (2024). Multicellular 3D bioprinted human gallbladder carcinoma for in vitro mimicry of tumor microenvironment and intratumoral heterogeneity. Biofabrication. 16(4). 45028–45028. 3 indexed citations
8.
9.
Ding, Peiwen, Xueshuai Wan, Gang Xu, et al.. (2023). Application and Progress of Cultured Models of Gallbladder Carcinoma. Journal of Clinical and Translational Hepatology. 0(0). 0–0. 5 indexed citations
10.
Jin, Bao, Haifeng Xu, Xin Lü, et al.. (2023). Immune checkpoint inhibitor‐related molecular markers predict prognosis in extrahepatic cholangiocarcinoma. Cancer Medicine. 12(20). 20470–20481. 2 indexed citations
11.
Lü, Lin, Huijuan Zhu, Yu Xiao, et al.. (2022). Somatostatin Treatment for Ectopic ACTH Syndrome due to Pancreatic Neuroendocrine Tumors: Review of the Literature. International Journal of Endocrinology. 2022. 1–10. 1 indexed citations
12.
Xu, Nan, Zhiyong Zhang, Bo Zhu, et al.. (2022). Ultrasound-Guided Continuous Thoracic Paravertebral Block Improves Patientʼs Quality of Recovery After Open Hepatectomy: A Randomized, Double-Blind, Placebo-Controlled Trial. Chinese Medical Sciences Journal. 37(1). 15–22. 1 indexed citations
13.
Wang, Weibing, et al.. (2020). Coinfection of SARS-CoV-2 and Other Respiratory Pathogens. SHILAP Revista de lepidopterología. 3 indexed citations
14.
Sun, Lijiang, Dawei Wang, Minming Zhang, et al.. (2020). Preoperative Immune Prognostic Index Can Predict the Clinical Outcomes of Patients with Gallbladder Cancer: Single-Center Experience. SHILAP Revista de lepidopterología. 1 indexed citations
15.
Jin, Bao, Yue Shi, Haifeng Xu, et al.. (2020). <p>Prognostic Nomogram That Predicts Overall Survival of Patients with Distal Cholangiocarcinoma After Pancreatoduodenectomy</p>. Cancer Management and Research. Volume 12. 10303–10310. 6 indexed citations
16.
Jin, Bao, Yue Shi, Haifeng Xu, et al.. (2020). <p>Preoperative Bilirubin-Adjusted Carbohydrate Antigen 19-9 as a Prognostic Factor for Extrahepatic Cholangiocarcinoma Patients at a Single Center</p>. Cancer Management and Research. Volume 12. 411–417. 2 indexed citations
17.
Zheng, Yongchang, Fucun Xie, Kai Kang, et al.. (2019). Hepatobiliary case report and literature review of hepatic reactive lymphoid hyperplasia with positive anti-smooth muscle antibody and anti-nuclear antibody tests. Translational Cancer Research. 8(3). 1001–1005. 1 indexed citations
18.
Du, Shunda, Lijian Pei, Bo Zhu, et al.. (2017). Role of a selective cyclooxygenase-2 inhibitor on pain and enhanced recovery after open hepatectomy: a randomized controlled trial. Translational Cancer Research. 6(4). 806–814. 3 indexed citations
19.
Du, Shunda, Gang Liu, Xinqi Cheng, et al.. (2016). Differential Diagnosis of Immunoglobulin G4-associated Cholangitis From Cholangiocarcinoma. Journal of Clinical Gastroenterology. 50(6). 501–505. 14 indexed citations
20.
Xu, Yiyao, Huayu Yang, Yilei Mao, et al.. (2016). Application of associating liver partition and portal vein ligation for staged hepatectomy(ALPPS) in cirrhotic patients with hepatocellular carcinoma. Zhonghua putong waike zazhi. 31(7). 534–537. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiangcheng Li Breakdown of academic impact, for papers by Francesco Vasuri Breakdown of academic impact, for papers by Eun Sun Jung Breakdown of academic impact, for papers by Xin Yin Breakdown of academic impact, for papers by Xiaolu Ma Breakdown of academic impact, for papers by Hee Chul Yu Breakdown of academic impact, for papers by Patrick Starlinger Breakdown of academic impact, for papers by Klaus J. Schmitz Breakdown of academic impact, for papers by Feng Han Breakdown of academic impact, for papers by Xiaoping Chen
Rankless by CCL
2026